Literature DB >> 21074425

In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).

Karen A Nolan1, Mary C Caraher, Matthew P Humphries, Hoda Abdel-Aal Bettley, Richard A Bryce, Ian J Stratford.   

Abstract

The NCI chemical database has been screened using in silico docking to identify novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Compounds identified from the screen exhibit a diverse range of scaffolds and inhibitory potencies are generally in the micromolar range. Some of the compounds also have the ability to inhibit NQO1. The modes of binding of the different compounds to the two enzymes are illustrated and discussed.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074425     DOI: 10.1016/j.bmcl.2010.10.070

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-κB signaling.

Authors:  Karen A Nolan; Mark S Dunstan; Mary C Caraher; Katherine A Scott; David Leys; Ian J Stratford
Journal:  Mol Cancer Ther       Date:  2011-11-16       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.